Disease-A-Month
Volume 55, Issue 11 , Pages 675-692 , November 2009

Sarcoidosis: Extrathoracic Manifestations

References 

  1. American Thoracic Society. Statement on sarcoidosis. Am J Respir Crit Care Med. 1999;160:736–755
  2. Judson M. Extrapulmonary sarcoidosis. Semin Respir Crit Care Med. 2007;28:83–101
  3. Baughman R, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case-control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885–1889
  4. Chapelon-Abric C, Zuttere D, Duhaut P, et al. Cardiac sarcoidosis. Medicine. 2004;83:315–333
  5. Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J. 2009;157:9–12
  6. Habersberger J, Manins V, Taylor AJ. Cardiac sarcoidosis. Intern Med J. 2008;38:270–277
  7. Ruiz-Arango A, Sharma G. Exercise intolerance and multiple conduction abnormalities as first manifestation of cardiac sarcoidosis. South Med J. 2008;101:1059–1061
  8. Winters S, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol. 1991;18:937–943
  9. Lubitz SA, Goldbarg SH, Mehta D. Sudden cardiac death in infiltrative cardiomyopathies: Sarcoidosis, scleroderma, amyloidosis, hemachromatosis. Prog Cardiovasc Dis. 2008;51:58–73
  10. Judson MA, Baughman RP, Teirstein AS, et al. Defining organ involvement in sarcoidosis: The ACCESS proposed instrument; ACCESS Research Group: A case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:75–86
  11. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88:1006–1010
  12. Okayama K, Kurata C, Tawarahara K, et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest. 1995;107:330–334
  13. Okumura W, Iwasaki T, Toyama T, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med. 2004;45:1989–1998
  14. Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: A 1-year follow-up study. Chest. 2002;122:1895–1901
  15. Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med. 2001;110:520–527
  16. Ichinose A, Otani H, Oikawa M, et al. MRI of cardiac sarcoidosis: Basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. AJR Am J Roentgenol. 2008;191:862–869
  17. King CS, Kelly W. Treatment of sarcoidosis. Dis Mon. 2009;55:704–718
  18. Burke WMJ, Keogh A, Maloney PJ, et al. Transmission of sarcoidosis via cardiac transplantation. Lancet. 1990;336:1579
  19. Milman N, Andersen CB, Mortensen SA, et al. Cardiac sarcoidosis and heart transplantation: A report of four consecutive patients. Sarcoidosis Vasc Diffuse Lung Dis. 2008;25:1–59
  20. Delaney P. Neurologic manifestations in sarcoidosis: Review of the literature, with a report of 23 cases. Ann Intern Med. 1977;87:336–345
  21. Murialdo G, Tamagno G. Endocrine aspects of neurosarcoidosis. J Endocrinol Invest. 2002;25:650–662
  22. Lower EE, Weiss KL. Neurosarcoidosis. Clin Chest Med. 2008;29:475–492
  23. Smith JK, Matheus MG, Castillo M. Imaging manifestations of neurosarcoidosis. AJR Am J Roentgenol. 2004;182:289–295
  24. Mafee MF, Dorodi S, Pai E. Sarcoidosis of the eye, orbit and central nervous system (Role of imaging). Radiol Clin North Am. 1999;37:73–87
  25. White ES, Lynch JP. Current and emerging strategies for the management of sarcoidosis. Exp Opin Pharmacother. 2007;8:1293–1311
  26. Park DJJ, Woog JJ, Pulido JS, et al. Minocycline for the treatment of ocular and ocular adnexal sarcoidosis. Arch Ophthalmol. 2007;125:705–709
  27. Doycheva D, Deuter C, Stuebiger N, et al. Interferon-alpha-associated presumed ocular sarcoidosis. Graefes Arch Clin Exp Ophthalmol. 2009;247:675–680
  28. Javaud N, Belenfant X, Stirnemann J, et al. Renal granulomatoses: A retrospective study of 40 cases and review of the literature. Medicine. 2007;86:170–180
  29. Bijol V, Mendez GP, Nose V, et al. Granulomatous interstitial nephritis (A clinicopathologic study of 46 cases from a single institution). Int J Surg Pathol. 2006;14:57–63
  30. Sharma OP. Renal sarcoidosis and hypercalcemia. Eur Respir J Monogr. 2005;10:220–232
  31. Warshauer DM, Lee JK. Imaging manifestations of abdominal sarcoidosis. AJR Am J Roentgenol. 2004;182:15–28
  32. Bergner R, Hoffmann M, Waldherr R, et al. Frequency of kidney disease in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:126–132
  33. Heldmann M, Behm W, Madhusudhan PR, et al. Pseudotumoral renal sarcoid: MRI, PET, and MDCT appearance with pathologic correlation. AJR Am J Roentgenol. 2005;185:697–699
  34. Yu TM, Lin SH, Ya-Wen C, et al. A syndrome resembling Bartter's syndrome in sarcoidosis. Nephrol Dial Transplant. 2009;24:667–669
  35. Awasthi A, Nada R, Malhotra P, et al. Fatal renal failure as the first manifestation of sarcoidosis diagnosed on necropsy in a young man: A case report. J Clin Pathol. 2004;57:1101–1103
  36. Piscioli I, Donato S, Morelli L, et al. Renal cell carcinoma with sarcomatoid features and peritumoral sarcoid-like granulomatous reaction: Report of a case and review of the literature. Int J Surg Pathol. 2008;16:345–348
  37. Rajakariar R, Sharples EJ, Rafery MJ, et al. Sarcoid tubulointerstitial nephritis: Long-term outcome and response to corticosteroid therapy. Kidney Int. 2006;70:165–169
  38. Ito S, Harada T, Nakamura T, et al. Mizoribine for renal sarcoidosis: Effective steroid tapering and prevention of recurrence. Pediatr Nephrol. 2009;24:411–414
  39. Moudgil A, Przygodzki RM, Kher KK. Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil. Pediatr Nephrol. 2006;21:281–285
  40. Ahmed MM, Mubashir E, Dossabhoy NR. Isolated renal sarcoidosis: A rare presentation of a rare disease treated with infliximab. Clin Rheumatol. 2007;26:1346–1349
  41. Volpicelli G, Mussa A, Frascisco M. A case of severe hypercalcemia with acute renal failure in sarcoidosis (A diagnostic challenge for the emergency department). Eur J Emerg Med. 2005;12:320–321
  42. Marchell RM, Judson MA. Chronic cutaneous lesions of sarcoidosis. Clin Dermatol. 2007;25:295–302
  43. Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis: A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164:2085–2091
  44. Mana J, Marcoval J, Graells J, et al. Cutaneous involvement in sarcoidosis (Relationship to systemic disease). Arch Dermatol. 1997;133:882–888
  45. Löfgren S, Lundback H. The bilateral hilar lymphoma syndrome: A study of the relation to tuberculosis and sarcoidosis in 212 cases. Acta Med Scand. 1952;142:265–273
  46. Neville E, Walker AN, James DGT. Prognostic factors predicting the outcome of sarcoidosis: An analysis of 818 patients. Q J Med. 1983;52:525–533
  47. Grunewald J, Eklaund A. Sex-specific manifestations of Lofgren's syndrome. Am J Respir Crit Care Med. 2007;175:40–44
  48. Requena L, Requena C. Erythema nodosum. Dermatol Online J. 2002;8:4
  49. Jones JV, Cumming RH, Asplin CM. Evidence for circulating immune complexes in erythema nodosum and early sarcoidosis. Ann NY Acad Sci. 1976;278:212–219
  50. Fernandez-Faith E, McDonnell J. Cutaneous involvement in sarcoidosis: Differential diagnosis. Clin Dermatol. 2007;25:276–287
  51. Rose AS, Tielker MA, Knox KS. Hepatic, ocular, and cutaneous sarcoidosis. Clin Chest Med. 2008;29:509–524
  52. ACCESS Research Group. Design of A case control etiology study of sarcoidosis (ACCESS). J Clin Epidemiol. 1999;52:1173–1186
  53. Kahi CJ, Saxena R, Temkit M, et al. Hepatobiliary disease in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23:117–123
  54. Devaney K, Goodman ZD, Epstein MS, et al. Hepatic sarcoidosis: Clinicopathologic features in 100 patients. Am J Surg Pathol. 1993;17:1272–1280
  55. Israel HL, Margolis ML, Rose LJ. Hepatic granulomatosis and sarcoidosis. Digest Dis Sci. 1984;29:353–356
  56. Kataria YP, Whitcomb ME. Splenomegaly in sarcoidosis. Arch Intern Med. 1980;140:35–37
  57. Selroos O, Koivunen E. Usefulness of fine needle aspiration biopsy of spleen in diagnosis of sarcoidosis. Chest. 1983;83:193–195
  58. Visser H, Vos K, Zanelli E, et al. Sarcoid arthritis: Clinical characteristics, diagnostic aspects, and risk factors. Ann Rheum Dis. 2002;61:499–504
  59. Jansen TLTA, Geusens PPMM. Sarcoidosis: Joint, muscle, and bone involvement. Eur Respir J Monogr. 2005;10:210–219
  60. Mana J, Gomez-Vaquero C, Salazar A, et al. Periarticular ankle sarcoidosis: A variant of Lofgren's syndrome. J Rheumatol. 1996;23:874–877
  61. Glennas A, Kvein TK, Melby K, et al. Acute sarcoid arthritis: Occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol. 1995;34:45–50
  62. Moore SL, Teirstein A, Golimbu C. MRI of sarcoidosis patients with musculoskeletal symptoms. AJR Am J Roentgenol. 2005;185:154–159
  63. Vahid B, Spodik M, Braun KN, et al. Sarcoidosis of gastrointestinal tract: A rare disease. Digest Dis Sci. 2007;52:3316–3320
  64. Reineke EZ, MacLennan GT. Sarcoidosis of the testis and epididymis. J Urol. 2008;179:1147
  65. Furusato B, Koff S, McLeod DG, et al. Sarcoidosis of the prostrate. J Clin Pathol. 2007;60:325–326
  66. Sharma OP. Sarcoidosis of the upper respiratory tract: Selected cases emphasizing diagnostic and therapeutic difficulties. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:227-3
  67. Lower EE. Rare forms of sarcoidosis. In:  Baughman RP editors. Sarcoidosis: Lung Biology in Health And Disease. 210:New York: Marcel Dekker; 2006;p. 651–670
  68. Gansler TS, Wheeler JE. Mammary sarcoidosis: Two cases and literature review. Arch Pathol Lab Med. 1984;108:673–675
  69. Isern V, Lora-Tamayo J, Capdevila O, et al. Sarcoidosis and autoimmune thyroid disease (A case series of ten patients). Sarcoidosis Vasc Diffuse Lung Dis. 2007;24:148–152

 No financial or other potential conflicts of interest exist for the above authors. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Army, Department of Defense, or the U.S. Government.

PII: S0011-5029(09)00067-4

doi: 10.1016/j.disamonth.2009.05.002

Disease-A-Month
Volume 55, Issue 11 , Pages 675-692 , November 2009